Literature DB >> 36121635

miR-188-5p and Host MALAT1 Regulate RBE Cell Migration, Invasion, and Apoptosis via Up-regulating PSMD10 in Cholangiocarcinoma.

Zhaoqiang Yin1, Jianlong Wang1, Tao Li1, Lifeng Ma1, Jiansheng Kang1, Guochao Liu2.   

Abstract

The study is designed to explore the regulatory network that MALAT1 competitively binds with miR-188-5p to up-regulate PSMD10 to facilitate cholangiocarcinoma cell migration and invasion and suppress apoptosis. qRT-PCR and fluorescence in situ hybridization (FISH) were used to examine the expression and positive signal of MALAT1 and miR-188-5p in cholangiocarcinoma tissues and HIBEC, HCCC-9810, RBE, and QBC939 cells. Western blot, qRT-PCR, and immunohistochemistry were selected to detect PSMD10 expression in cholangiocarcinoma tissues and cell lines. Dual luciferase reporter gene assay was adopted to verify that miR-188-5p targeted MALAT1 and PSMD10. qRT-PCR, pull down, and western blot were used to examine the regulation of MALAT1-miR-188-5p-PSMD10 axis. Transwell, wound healing assay, and Tunel cell apoptosis were adopted to respectively detect the regulatory abilities of MALAT1-miR-188-5p-PSMD10 axis on cell invasion, migration, and apoptosis. Western blot was used to detect the regulation mechanism of MALAT1 on Bax, Bcl-2, and caspase-3 proteins. Nude mice subcutaneous xenograft model of cholangiocarcinoma was established to examine the impacts of MALAT1 on subcutaneous tumor growth. Immunohistochemistry was adopted to examine the positive indicator of Ki67 antibodies and SMD10 antibodies in each group. MALAT1 and PSMD10 were highly expressed in cholangiocarcinoma tissues and cell lines, while miR-188-5p was lowly expressed. MALAT1 could competitively bind to miR-188-5p, and miR-188-5p could negatively regulate PSMD10. MALAT1, In-miR-188-5p, and PSMD10 could facilitate cell invasion and migration and inhibit apoptosis, while siMALAT1, miR-188-5p, and siPSMD10 produced an opposite result. MALAT1-miR-188-5p-PSMD10 axis could promote RBE cell invasion and migration and inhibit apoptosis, whereas siMALAT1-In-miR-188-5p-siPSMD10 axis showed an opposite result. On the other hand, it was verified that up-regulation/down-regulation of MALAT1 can inhibit/promote Bax and caspase-3 proteins and promote/inhibit the expression of Bcl-2 protein. MALAT1 could facilitate subcutaneous tumor growth and enhance cell proliferation and positive signal of PSMD10, while miR-188-5p worked in an opposite direction. MALAT1 competitively binds to miR-188-5p to up-regulate mRNA translation and protein expression of PSMD10, thereby facilitating cholangiocarcinoma cell invasion and migration and inhibiting its apoptosis. However, interfering MALAT1-miR-188-5p-PSMD10 axis could inhibit the occurrence and development of cholangiocarcinoma.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cholangiocarcinoma; MALAT1; PSMD10; RBE; miR-188-5p

Year:  2022        PMID: 36121635     DOI: 10.1007/s12010-022-04136-8

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   3.094


  38 in total

Review 1.  Revealing lncRNA Structures and Interactions by Sequencing-Based Approaches.

Authors:  Xingyang Qian; Jieyu Zhao; Pui Yan Yeung; Qiangfeng Cliff Zhang; Chun Kit Kwok
Journal:  Trends Biochem Sci       Date:  2018-11-17       Impact factor: 13.807

Review 2.  Cholangiocarcinoma - evolving concepts and therapeutic strategies.

Authors:  Sumera Rizvi; Shahid A Khan; Christopher L Hallemeier; Robin K Kelley; Gregory J Gores
Journal:  Nat Rev Clin Oncol       Date:  2017-10-10       Impact factor: 66.675

Review 3.  Intrahepatic Cholangiocarcinoma.

Authors:  Ramy El-Diwany; Timothy M Pawlik; Aslam Ejaz
Journal:  Surg Oncol Clin N Am       Date:  2019-10       Impact factor: 3.495

4.  Transcription factor HIF1α promotes proliferation, migration and invasion of cholangiocarcinoma via long non-coding RNA H19/microRNA-612/Bcl-2 axis.

Authors:  Aijun Yu; Luwen Zhao; Qingmin Kang; Jian Li; Kai Chen; Hua Fu
Journal:  Transl Res       Date:  2020-06-04       Impact factor: 7.012

Review 5.  Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer.

Authors:  Bela Goyal; Shashi Ranjan Mani Yadav; Nikee Awasthee; Sweety Gupta; Ajaikumar B Kunnumakkara; Subash Chandra Gupta
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2021-01-08       Impact factor: 10.680

6.   Intrahepatic, perihilar and distal cholangiocarcinoma: Management and outcomes.

Authors:  David Waseem; Patel Tushar
Journal:  Ann Hepatol       Date:  2017 Jan-Feb 2017       Impact factor: 2.400

Review 7.  Cholangiocarcinoma.

Authors:  Nataliya Razumilava; Gregory J Gores
Journal:  Lancet       Date:  2014-02-26       Impact factor: 79.321

8.  MALAT1 promotes angiogenesis of breast cancer.

Authors:  Xiao-Juan Huang; Yu Xia; Gui-Fang He; Lu-Lu Zheng; Yong-Ping Cai; Yu Yin; Qiang Wu
Journal:  Oncol Rep       Date:  2018-09-13       Impact factor: 3.906

Review 9.  Cholangiocarcinoma: Current Knowledge and New Developments.

Authors:  Boris Blechacz
Journal:  Gut Liver       Date:  2017-01-15       Impact factor: 4.519

10.  LncRNA TUG1 Promotes Growth and Metastasis of Cholangiocarcinoma Cells by Inhibiting miR-29a.

Authors:  Wei Yuan Hao; Li Wen Guo; Jun Luo; Guo Liang Shao; Jia Ping Zheng
Journal:  Cancer Manag Res       Date:  2020-11-02       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.